Mobile

A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001431-30

A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) versus Efavirenz (EFV) plus TDF and FTC in Antiretroviral-Naïve HIV-1/HCV Co-infected Subjects

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the safety, tolerability, and antiviral activity of two treatment strategies in HIV-1/HCV co-infected subjects: -LPV/r-based induction/maintenance strategy; -EFV-based three-drug regimen.

Critère d'inclusion

  • HIV-1 infection

Liens